TipRanks
Thomson Medical Group Ltd. (DE:3H5)
FRANKFURT:3H5
Germany Market
3H5
Thomson Medical Group Ltd.
RESEARCH TOOLSreports

Thomson Medical Group Ltd. (3H5) Ratios

0 Followers

Thomson Medical Group Ltd. Ratios

DE:3H5's free cash flow for Q3 2025 was S$0.43. For the 2025 fiscal year, DE:3H5's free cash flow was decreased by S$ and operating cash flow was S$0.11. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 ― 1.04 1.19 1.08 3.67
Quick Ratio
 ― 0.57 0.67 0.72 2.91
Cash Ratio
 ― 0.36 0.46 0.57 2.39
Solvency Ratio
 ― <0.01 >-0.01 0.03 0.07
Operating Cash Flow Ratio
 ― 0.23 0.22 0.29 0.74
Short-Term Operating Cash Flow Coverage
 ― 0.35 0.37 0.44 7.30
Net Current Asset Value
S$ ―S$ -924.98MS$ -916.61MS$ -915.61MS$ -431.45M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.64 0.63 0.62 0.53
Debt-to-Equity Ratio
 ― 2.55 2.38 2.24 1.53
Debt-to-Capital Ratio
 ― 0.72 0.70 0.69 0.60
Long-Term Debt-to-Capital Ratio
 ― 0.67 0.67 0.65 0.60
Financial Leverage Ratio
 ― 4.01 3.79 3.62 2.90
Debt Service Coverage Ratio
 ― 0.25 0.23 0.41 2.17
Interest Coverage Ratio
 ― 0.53 0.27 1.43 2.70
Debt to Market Cap
 ― 0.80 0.97 0.84 0.48
Interest Debt Per Share
 ― 0.04 0.04 0.04 0.03
Net Debt to EBITDA
 ― 14.72 17.28 8.75 4.46
Profitability Margins
Gross Profit Margin
―73.76%74.83%78.43%83.31%
EBIT Margin
―6.68%4.82%22.98%24.09%
EBITDA Margin
―16.44%14.63%31.06%30.02%
Operating Profit Margin
―6.26%4.03%20.94%23.12%
Pretax Profit Margin
―-5.03%-10.29%8.30%15.52%
Net Profit Margin
―-7.07%-12.05%4.03%10.27%
Continuous Operations Profit Margin
―-6.62%-11.90%5.19%11.54%
Net Income Per EBT
―140.61%117.13%48.56%66.22%
EBT Per EBIT
―-80.33%-255.36%39.65%67.11%
Return on Assets (ROA)
―-1.67%-2.67%0.78%2.52%
Return on Equity (ROE)
―-6.71%-10.10%2.83%7.32%
Return on Capital Employed (ROCE)
―1.80%1.05%4.85%6.20%
Return on Invested Capital (ROIC)
―1.57%0.94%2.68%4.54%
Return on Tangible Assets
―-3.02%-4.96%1.55%3.78%
Earnings Yield
―-2.16%-4.18%1.07%2.34%
Efficiency Ratios
Receivables Turnover
 ― 6.68 9.14 10.84 6.46
Payables Turnover
 ― 1.26 5.64 5.08 4.67
Inventory Turnover
 ― 0.75 0.72 0.71 0.65
Fixed Asset Turnover
 ― 0.82 0.79 0.72 0.83
Asset Turnover
 ― 0.24 0.22 0.19 0.25
Working Capital Turnover Ratio
 ― 13.23 10.45 2.03 2.35
Cash Conversion Cycle
 ― 254.01 485.30 473.36 542.65
Days of Sales Outstanding
 ― 54.65 39.95 33.66 56.46
Days of Inventory Outstanding
 ― 489.33 510.12 511.61 564.40
Days of Payables Outstanding
 ― 289.97 64.76 71.91 78.21
Operating Cycle
 ― 543.98 550.06 545.27 620.86
Cash Flow Ratios
Operating Cash Flow Per Share
 ― <0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
 ― <0.01 <0.01 <0.01 <0.01
CapEx Per Share
 ― <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 ― 0.72 0.56 0.64 0.86
Dividend Paid and CapEx Coverage Ratio
 ― 3.55 2.27 2.04 2.05
Capital Expenditure Coverage Ratio
 ― 3.55 2.27 2.75 6.93
Operating Cash Flow Coverage Ratio
 ― 0.06 0.05 0.07 0.12
Operating Cash Flow to Sales Ratio
 ― 0.17 0.15 0.24 0.25
Free Cash Flow Yield
―3.71%2.97%4.01%4.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -47.27 -23.89 93.39 42.68
Price-to-Sales (P/S) Ratio
 ― 3.27 2.88 3.76 4.38
Price-to-Book (P/B) Ratio
 ― 3.11 2.41 2.65 3.12
Price-to-Free Cash Flow (P/FCF) Ratio
 ― 26.97 33.65 24.95 20.58
Price-to-Operating Cash Flow Ratio
 ― 19.38 18.81 15.86 17.61
Price-to-Earnings Growth (PEG) Ratio
 ― 1.22 0.05 -1.45 -1.42
Price-to-Fair Value
 ― 3.11 2.41 2.65 3.12
Enterprise Value Multiple
 ― 34.63 36.97 20.87 19.07
Enterprise Value
 ― 2.39B 2.13B 2.28B 2.04B
EV to EBITDA
 ― 34.63 36.97 20.87 19.07
EV to Sales
 ― 5.69 5.41 6.48 5.72
EV to Free Cash Flow
 ― 46.92 63.17 42.95 26.86
EV to Operating Cash Flow
 ― 33.71 35.31 27.31 22.98
Tangible Book Value Per Share
 ― -0.01 -0.01 -0.01 <0.01
Shareholders’ Equity Per Share
 ― 0.02 0.02 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
 ― -0.32 -0.16 0.38 0.26
Revenue Per Share
 ― 0.02 0.01 0.01 0.01
Net Income Per Share
 ― >-0.01 >-0.01 <0.01 <0.01
Tax Burden
 ― 1.41 1.17 0.49 0.66
Interest Burden
 ― -0.75 -2.13 0.36 0.64
Research & Development to Revenue
 ― 0.00 0.00 0.00 0.00
SG&A to Revenue
 ― 0.00 0.00 >-0.01 >-0.01
Stock-Based Compensation to Revenue
 ― <0.01 >-0.01 <0.01 <0.01
Income Quality
 ― -3.36 -1.49 2.86 1.60
Currency in SGD